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We have characterized a rodent-specific gene
family designated a-takusan (meaning ‘‘many’’
in Japanese). We initially identified a member
of the family whose expression is upregulated
in mice lacking the NMDAR subunit NR3A. We
then isolated cDNAs encoding 46 a-takusan
variants from mouse brains. Most variants
share an 130 aa long sequence, which con-
tains the previously identified domain of un-
known function 622 (DUF622) and is predicted
to form coiled-coil structures. Single-cell PCR
analyses indicate that one neuron can express
multiple a-takusan variants and particular vari-
ants may predominate in certain cell types.
Forced expression in cultured hippocampal
neurons of two variants, a1 or a2, which bind ei-
ther directly or indirectly to PSD-95, leads to an
increase in PSD-95 clustering, dendritic spine
density, GluR1 surface expression, and AMPAR
activity. Conversely, treating cultured neurons
with RNAi targeting a-takusan variants resulted
in the opposite phenotype. Hence, a-takusan
represents a large gene family that regulates
synaptic activity.
INTRODUCTION
NMDA-type glutamate receptors (NMDARs) are thought
to act as integrators of coincident synaptic signals (Mal-
enka and Nicoll, 1999), while their hyperactivation causes
neurodegeneration (Cull-Candy et al., 2001; Dingledine
et al., 1999; Lipton and Rosenberg, 1994). The conven-
tional NMDAR requires two distinct subunits, NR1 and
NR2, to form functional channels (Dingledine et al.,
1999; Hollmann and Heinemann, 1994). We and others
have identified a third family of NMDAR subunits, desig-
nated NR3 (Ciabarra et al., 1995; Das et al., 1998; Sucher
et al., 1995). In heterologous expression systems, inclu-sion of NR3A decreases the amplitude, Ca2+ permeability,
and Mg2+ sensitivity of NR1/NR2 channels (Chatterton
et al., 2002; Ciabarra et al., 1995; Das et al., 1998;
Perez-Otano et al., 2001; Sasaki et al., 2002; Sucher
et al., 1995). Consistent with these findings, the amplitude
of NMDA currents in NR3A knockout (KO) neurons is
larger than that of wild-type (WT) neurons (Das et al.,
1998; Sasaki et al., 2002). Hence, NR3A is considered to
act as an inhibitory subunit of NMDAR. Concomitantly,
NR3A might control trafficking of NMDARs (Perez-Otano
et al., 2006).
NMDARs are clustered in the postsynaptic density
(PSD) at excitatory synapses (Nourry et al., 2003; Sheng,
2001; Sheng and Sala, 2001). This is likely mediated by
physical association between C-terminal ends of NR2
and PDZ domains of postsynaptic scaffolding proteins
such as PSD-95 (Kornau et al., 1995; Niethammer et al.,
1996). PDZ domains are modular protein domains of
90 amino acids that are used for protein-protein interac-
tions, and each PDZ domain binds to C-terminal peptides
in a sequence-specific manner (Kim et al., 1995; Kornau
et al., 1995; Mori et al., 1998; Niethammer et al., 1996;
Songyang et al., 1997; Steigerwald et al., 2000). For exam-
ple, a class I PDZ domain prefers the C-terminal tail -S/T-
X-V/L/I as its binding partner. In addition to NR2 subunits,
PSD-95 binds to various other proteins, such as stargazin
(Schnell et al., 2002), and organizes postsynaptic supra-
molecular complexes (Husi et al., 2000; Kim and Sheng,
2004). Interestingly, forced expression of PSD-95 in cul-
tured hippocampal neurons enhances postsynaptic clus-
tering of AMPA, but not NMDA, receptors (El-Husseini
et al., 2000), and the function of PSD-95 is further regu-
lated by its palmitoylation (El-Husseini et al., 2002). These
and other studies have identified molecules that regulate
trafficking and localization of AMPA-receptor subunits (re-
viewed in Barry and Ziff, 2002; Malinow and Malenka,
2002; Nicoll et al., 2006; Song and Huganir, 2002).
Since neurons in NR3A KO mice manifest increased
NMDA-induced currents, we reasoned that these mice
might allow us to identify components of signal transduc-
tion pathways downstream from NMDAR hyperactivation.
In turn, these genes may represent candidate moleculesNeuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc. 69
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Takusan Gene Family Regulates Synaptic ActivityFigure 1. a1-Takusan Is Upregulated in
NR3A KO Mice
(A) Microarray probed with cDNAs prepared
fromWT and NR3A KO brains. Arrows indicate
duplicate spots corresponding to a1-takusan.
(B) Q-PCR confirmed the results of the micro-
array experiments. The expression level of
a-takusanmRNA inNR3A KObrain is 2.6 times
higher than that inWT brain (mean ± SEM; **p <
0.01).
(C) Deduced amino acid sequence of a1-taku-
san. The residues in blue (1–66) show homol-
ogy with DUF622. The residues at the C-termi-
nal end form a motif that is predicted to bind to
class I PDZ domains. The underlined letters (R,
S, and S) indicate the end of exons 4, 5, and 6.
The serine in red is a candidate for phosphory-
lation by protein kinases A and C.
(D) In situ hybridization was performed using
a pan a-takusan probe on WT and NR3A KO
brain sections at P15. a-Takusan mRNA is
more abundant in KO than in WT in regions
such as the amygdala and hippocampus.
Scale bar, 100 mm.
(E) Northern blot of a-takusan mRNAs in WT
and NR3A KO mice in three areas of the brain.
RNAs from the cerebral cortex (lane 1,WT; lane
2, KO), hippocampus (lane 3, WT; lane 4, KO),
and cerebellum (lane 5, WT; lane 6, KO) were
hybridized with probes for a1-takusan or con-
trol tubulin. The signals from the three areas
of the KO mice are 2 to 3 times higher than
those of WT mice.that are involved in the manifestation of the phenotypes
observed in NR3A KO mice, including increased dendritic
spines (Das et al., 1998). Specifically, we screened for
genes whose expression was altered in NR3A KO brains
compared to WT brains. We identified such a gene and
found that it belonged to a very large gene family whose
members shared a domain of 130 amino acids (aa). A
portion of this domain had previously been termed domain
of unknown function 622 (DUF622), which is 85 aa in
length and predicted to form a coiled-coil structure. One
example of a protein that contains DUF622 is the human
tumor suppressor gene discs large (Dlg) 5 that also con-
tains PDZ and guanylate-kinase domains (Stoll et al.,
2004). However, the majority of proteins with DUF622
are 150–250 aa long and contain no other known domains.
Because of the size of this family of genes, we have named
it takusan, a Japanese word that means ‘‘many.’’
In this paper, we describe our initial characterization of
a-takusan, a subclass of the takusan family. We show that
more than 40 members of a-takusan are expressed in the
mouse brain. Single-cell PCR analyses indicate that indi-
vidual neurons can express multiple a-takusan variants
and that different neurons may express different sets of
a-takusan. In transfected COS-7 cells, certain a-takusan
variants bind to PSD-95, while other variants do not, pre-
sumably due to their structural diversity at the C termini.
We then force expressed fusion proteins of enhanced
green fluorescent protein (EGFP) and a1 (PSD-95 binding)70 Neuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc.or a2 (PSD-95 nonbinding) variants of takusan in cultured
hippocampal neurons. Examining the localization of taku-
san family members fused to EGFP, we found that EGFP-
a1 signals were often colocalized with PSD-95, while
EGFP-a2 signals were colocalized with or adjacent to
PSD-95 signals. In coimmunoprecipitation experiments,
a1 bound directly to PSD-95, while a2 bound indirectly
via complex formation with a1. Forced expression of
EGFP-a1 or -a2 enhanced clustering of PSD-95, dendritic
spine density, surface expression of GluR1, and AMPA-
receptor activity, whereas RNAi for takusan variants abro-
gated these effects. Interestingly, forced expression of
EGFP-a1, but not -a2, altered desensitization of NMDA-
induced currents.
RESULTS
Identification of a1-Takusan as a Gene Upregulated
in NR3A KO Mice
We searched for genes whose expression levels are al-
tered in NR3A KO. To this end, we extracted RNAs from
the whole brains of NR3A KO and littermate WT mice in
a 129/SVJ background on postnatal day 15 (P15), synthe-
sized cDNAs, and then used them to probe mouse cDNA
microarrays (NIA mouse 15k, Ontario Cancer Institute).
From these experiments, we identified a gene whose ex-
pression level is higher in NR3A KO brains than in WT
brains by more than 2-fold (Figure 1A). We identified the
Neuron
Takusan Gene Family Regulates Synaptic Activitygene that corresponds to the spots on the array as Riken
cDNA clone 2610042L04 (Carninci and Hayashizaki, 1999;
Kawai et al., 2001). This cDNAcontains a 150 aa open read-
ing frame (ORF), and its gene function was previously
unknown. We named this gene the a1 form of takusan, or
a1-takusan, because it belongs to a large gene family. We
verified the microarray data by quantitative (Q)-PCR in
which the level of a1-takusan mRNA was normalized to
that of a reference gene, glyceraldehyde-3-phosphate de-
hydrogenase (GADPH). We found that a1-takusan mRNA
is expressed at a rate 2.6 times higher in NR3A KO mouse
brains than in WT brains at P15 (Figure 1B).
Figure 1C shows the deduced amino acid sequence of
a1-takusan that we isolated from WT brains of C57BL/6J
mice. The coding sequence of a1-takusan was assigned
to an ORF near the 50 end of the cDNA, based on the co-
don-usage index and its surrounding sequences. This as-
signment is likely correct, because this ORF would pro-
duce a protein that contains a portion of the domain that
is conserved among a large number of proteins. This
domain, previously designated DUF622 at Pfam (www.
sanger.ac.uk/Software/Pfam), is 85 aa long and over-
laps with the N-terminal half (residues 1–76) of a-takusan.
Garnier-Robson and Chou-Fasman algorithms predict
that a1-takusan forms an a-helical structure through
much of the coding region. Furthermore, the COILS pro-
gram (www.ch.embnet.org/software/COILS_form.html)
predicts that two separate coiled-coil domains (residues
1–37 and 84–123) will be formed in this protein. The Scan-
site 2.0 program (Obenauer et al., 2003) identified a phos-
phorylation site for both protein kinase A (PKA) and protein
kinase C (PKC) at Serine 131, as well as a candidate motif
for PDZ binding at the C terminus of a1-takusan. We also
determined exon boundaries within the coding region of
the a1-takusan gene by comparing cDNA and genomic
sequences using the search program BLAT (http://
genome.ucsc.edu/cgi-bin/hgBlat). The coding region of
this gene is encoded by four separate exons (exons 4–
7), which are preceded by three exons encoding 50-UTR.
Expression Patterns of a-Takusan mRNA in WT
and NR3A KO Mice
Using a part of the a1-takusan cDNA as a probe, we per-
formed in situ hybridization on NR3A KO and WT at P15
(Figure 1D). The probe spans 363 nucleotides (nt) of the
a1-takusan coding region and 279 nt of the 30-UTR se-
quences. This probe contains the entire exons 5 and 6
and would thus likely hybridize with other a-takusan vari-
ants (see below). We found that a-takusan mRNA is ex-
pressed inWT brains in the hippocampus, cerebral cortex,
amygdala, and cerebellum. In contrast, the level of a-taku-
san expression is significantly increased inNR3A KOmice
in brain areas including the cerebral cortex layer V, hippo-
campal CA2-3 region, amygdala, and cerebellar Purkinje
cells. These areas normally express NR3A in WT mice
(Wong et al., 2002). These data suggest that, at least ini-
tially, the upregulation of a-takusan mRNA by a genetic
deletion of NR3A occurs in a cell-autonomous manner;namely, a-takusan is upregulated in KO mice in the cells
in which NR3A expression has been abolished.
We next examined a-takusan expression by northern
analyses. At P13, the level of a-takusan expression is
too low to be detectable in WT and KO mice (data not
shown). At P25, when normalized to tubulin expression,
KO mice expressed higher levels of a-takusan than WT
mice by 2- to 3-fold in the areas of the brain we examined
(Figure 1E). Again, the probe used in this studywould likely
hybridize to other a-takusan variants. We currently do not
know which form(s) of a-takusan is upregulated in KO
mice.
The studies described above focused on the upregula-
tion of a-takusan in NR3A KO mice. Throughout these
studies, we noticed that WT brains express a-takusan
mRNAs, although their expression levels are lower than
those in KO brains. To gain insight into the functions of
a-takusan, we examined the tissue distribution of a-taku-
sanmRNA inWTmice. As shown in Figure S1A in the Sup-
plemental Data available with this article online, we found
that a-takusan mRNA is expressed in two adult tissues,
the brain and testis, but not in heart, lung, liver, spleen,
skeletal muscles, or kidney. We next performed in situ hy-
bridization on male 6-week-old 129/SVJ WT brains. As
shown in Figure S1B, adult WT mice express a-takusan
in various areas of the brain. These areas include glomer-
ular and mitral cells of the olfactory bulb, the pyramidal
layer and dentate gyrus of the hippocampus, scattered
cells in the amygdala, cerebral cortex and facial nucleus,
and Purkinje neurons of the cerebellum.
a-Takusan Is an Unusually Large Gene Family
Prior to this study, there had been multiple cDNA entries
whose DNA sequences were highly homologous to a1-
takusan in GenBank. Many of these cDNAs were isolated
from the testis andwhole embryos by the Riken cDNApro-
ject. By comparing these genes, we found that these
genes were most conserved within the area encoded by
exon 5 of a1-takusan (residues 43–87, see Figure 1C).
When we used exon 5 of a1-takusan as a query in
BLASTN, we found 115 hits in the mouse genome. Most
hits correspond to genome sequences that are predicted
to encode proteins with >70% identity to exon 5 of a1-
takusan. We consider these genes to be candidate mem-
bers of the a-takusan gene family (see below on how we
define this family).
We next attempted to determine which members
of a-takusan were expressed in the brain. To this end,
four PCR primer pairs were designed from conserved
sequences of 50- and 30-UTRs of a-takusan. RT-PCR
was performed with RNAs extracted from a forebrain of
a WT C57BL/6 (male, 6-week-old) mouse. We chose this
strain because it was used for the genome sequencing
project. We identified 31 distinct members of a-takusan
expressed in a single brain (see Figure 2A and Figure S2
for their deduced amino acid sequences). Additional
a-takusan variants may also be expressed in the brain
(see below).Neuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc. 71
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Takusan Gene Family Regulates Synaptic ActivityFigure 2. Deduced Amino Acid Sequences and Gene Organization of Selected a-Takusan Variants
(A) Deduced amino acid sequences of a1–a6 takusan cDNAs isolated from WT C57BL/6 mouse brain. These six variants were used for the exper-
iments presented in Figure 4C. Twenty-five other variants (a7–a31) were also isolated from the same brain, and their deduced amino acid sequences
are presented in Figure S2. Typical exon boundaries are marked by ^. Nonconsensus amino acids are indicated in red.
(B) Location of exons encoding a-takusan protein sequences on a segment of chromosome 14. Exons 3–7 (the potential protein-coding region) of
a-takusan cDNA sequences were compared to the mouse genome using megaBLAST. The diagram at the bottom shows the positions of these
hits on a 3.5 Mb stretch using the Entrez Genomes MapViewer. An enlarged map of the 720 kb area that contains 15 apparent a-takusan loci is pre-
sented in three lines. See text for explanation of arrows in different colors.The alignment shown in Figure 2A and Figure S2 reveals
highly conserved amino acid sequences among a-taku-
san variants that we isolated.We compared cDNA and ge-
nomic sequences and found that variations observed in
cDNAs were also present in the mouse genome se-
quences. Therefore, it is unlikely that these variations are
products of RNA editing or mutations introduced during
PCR. From these alignments, we made the following ob-72 Neuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc.servations. (1) At the N terminus, the presence (or ab-
sence) of a termination codon at the 50-UTR creates vari-
ations in the starting ATG position. Due to this and other
reasons, a-takusan variants that we isolated differ in
size, ranging from 46 to 237 aa long (see also Figure S4A).
(2) The C termini vary inmultiple forms. Interestingly, some
a-takusan variants encode C-terminal sequences, such
as SSVI and GTAV, that are predicted to bind a class
Neuron
Takusan Gene Family Regulates Synaptic ActivityI PDZ domain, according to Scansite predictions (Son-
gyang et al., 1997). Other variants contain C-terminal se-
quences that are predicted not to bind PDZ domains.
These include variants that end with SSVK and EEEH.
(3) Multiple amino acid changes are present within the ta-
kusan domain, although many of these changes are con-
servative and may not alter protein properties. (4) Some
variants, such as a22, appear to lack exon 6 (see below).
Apparent loci for a-takusan are located on chromo-
somes 12, 14, and 17. In particular, a cluster of 75 a-
takusan loci is found within a 16 Mb region that corre-
sponds to 14A1 and 14A2 on chromosome 14. Figure 2B
shows the organization of exons for the potential coding
region of a-takusan in this area. The bottom map shows
the location of all hits with exons 3–7 of a1-takusan in
a 3.5 Mb region in the 16 Mb area. The upper diagram
shows exon-intron organization of 15 apparent a-takusan
loci, each of which encodes a different variant within an
720 Kb stretch. As shown in the figure, a-takusan genes
are located in both strands of the chromosome. The exon
organization in these loci sheds light on the origin of the di-
versity observed among various a-takusan cDNAs. The
first class of loci, indicated by green arrows in the figure,
consists of consecutive exons (3–7, 4–7, or 4–6), and
each locus appears to encode a typical ‘‘full-length’’ vari-
ant that is 148–205 aa long (see Figure S2). The second
class of loci, indicated by blue arrows, lack exon 6, and
thus these loci might directly encode shorter variants,
such as a22 (additional examples are presented in Fig-
ure S4A). This observation is interesting because these
shorter variants could potentially be produced from the
first class of loci by alternative splicing. Alternatively,
most of the shorter variants might be transcribed from
loci that lack exon 6. The third class of loci, indicated by
red arrows, contains tandem repeats of exon 4 or 7 within
a locus. These loci could possibly produce two variants
whose diversity is restricted to the N or C terminus by al-
ternative splicing. Examples of two variants that might
be produced by this mechanism are a14 and a18. It is
not possible, however, to definitively determine the locus
from which these two cDNAs are transcribed because
there are multiple loci whose sequences are very similar
to each other and to the two cDNAs. Finally, it is also pos-
sible, at least in theory, that alternative splicing occurs
across different loci. For example, an exon of one locus
might be spliced into an exon of another locus. In sum-
mary, an examination of the organization of the a-takusan
genes in the mouse genome leads to the notion that diver-
sity among variants is likely created by two distinct mech-
anisms: gene multiplication during evolution and alter-
native splicing.
Moreover, a-takusan appears to be only one branch of
a larger gene family. To examine this possibility, we used
a7-takusan, which contains an elongated N-terminal se-
quence, as a query to search for similar sequences in
the nr database at NCBI by BLASTP. We found 446 similar
proteins and extracted 157 mouse sequences, the major-
ity of which were annotated as hypothetical proteins. Wethen selected 51 sequences after removing highly similar
proteins (identity R95%), added a7-takusan, and built
an alignment using ClustalW (Figure S3A) to construct
a sequence similarity dendrogram (Figure S3B).
The dendrogram shows that a7-takusan belongs to one
(presented in green in Figure S3B) of three distinct
branches of the gene family. Based on this observation,
we define genes that belong to this branch as members
of the a-takusan gene family. The average sequence iden-
tity within this branch is 84.3%, while the minimum se-
quence identity within this group is 69.4%. We refer to
the members of the other branches as non-a forms of ta-
kusan. The exact size of the entire takusan gene family in
the mouse genome remains to be determined. The major-
ity of takusan genes, both a and non-a family members,
encode proteins of 150–220 aa. These proteins share a
conserved domain of 130 aa long, which contains the
previously identified DUF622 within its boundaries. Strik-
ingly, among the species for which genomic information
is available, the takusan gene family is present only in
mice and rats. As described in the Introduction, the human
tumor suppressor protein dlg 5 contains DUF622.
Different Neurons Express Different Sets
of a-Takusan Variants
Experiments described above show that mouse brain ex-
presses a large number of a-takusan variants. How does
the CNS exploit this molecular diversity? We therefore
asked (1) whether a single neuron expresses more than
one a-takusan and (2) whether different neurons express
different sets of a-takusan variants. To address these
questions, we examined cDNAs expressed in individual
neurons cultured from the hippocampus and cerebral cor-
tex of C57BL/6 mice dissected at E18 or P0 by single-cell
PCR techniques (Sucher and Deitcher, 1995).
We collected cytoplasmic samples from 22 hippocam-
pal and 22 cortical neurons and subjected them to RT-
PCR, which yielded PCR products of the appropriate
size from 11 hippocampal and 9 cortical cells. We then
cloned these products and determined the sequences of
five clones per cell. We identified a total of 22 distinct var-
iants expressed in these neurons (see Figure S4 for de-
duced amino acid sequences). Seven of these sequences
were identical to those isolated from the forebrain of the
adult mouse, while the other 15 were distinct. Therefore,
between the whole-brain and single-cell PCR analyses,
we have isolated 46 distinct a-takusan variants from a sin-
gle mouse strain (C57BL/6J).
In Table 1, we tabulate how each of the 22 a-takusan
variants is expressed in the 20 neurons we examined in
detail. Each variant is noted with its size, type based on
exon composition of the coding region (see Figure S4B),
and four amino acid residues at the C termini. As shown
below, theC-terminal residues of each takusan variant de-
termine the ability to bind PDZ domains. The variants that
are predicted to bind PDZ domains are presented in red,
while those that are predicted not to bind to PDZ domains
are in black in Table 1. Overall, we made the followingNeuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc. 73
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Takusan Gene Family Regulates Synaptic ActivityTable 1. Distribution of a-Takusan Variants in Hippocampal and Cortical Neurons
The numbers inside squares represent the numbers of clones isolated.observations. (1) Many neurons express more than one
a-takusan variant. (2) The repertoire of a-takusan variants
is different from neuron to neuron. Since identical PCR
conditions were used for all experiments, this likely re-
flects the difference in expression patterns of a-takusan
variants among these cells. Interestingly, there may be
a preference in the expression of certain types of a-taku-
san variants by particular cell types. For example, type I
a-takusan variants that end with XSVK were isolated in
only 1 out of 11 hippocampal neurons, but in 5 out of 9 cor-
tical neurons (p < 0.05, Fisher’s exact test). Conversely,
a-takusan variants that are predicted to bind PDZ do-
mains were detected in 6 out of 11 hippocampal neurons
(25 of 55 clones), while these variants were detected in
only 2 out of 9 cortical neurons (8 of 45 clones; p < 0.01
for clones, Fisher’s exact test).
a-Takusan Proteins Are Primarily Expressed
in Neurons
Wegenerated antibodies against a-takusan variants using
the peptide TKKRSKINELEELKLDMRK, whose sequence
was taken from the 2–20 position of a1-takusan. The pro-
tein sequences at this position are divergent between
a-takusan and non-a-takusan variants (see Figure S3A);
thus, the antibody we generated should be specific to
a-takusan. The sequence is strongly conserved among
all a-takusan variants that we isolated by PCR, thus the
antibody likely recognizes these a-takusan variants. How-74 Neuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc.ever, there are a-takusan variants whose sequence simi-
larity to a1-takusan in this area drops down to 50%.
We do not know whether our antibody recognizes these
a-takusan variants. Figure 3A shows an immunoblot of
the PSD fraction from the forebrain of an adult C57BL/6
WT mouse. The blot shows a major band at 17 kD that
was competed out when the antibody was preincubated
with antigenic peptides (data not shown). Since the calcu-
lated MW of the deduced a1-takusan protein is 17.7 kD,
this band is likely to represent a-takusan variants with
a protein size near 150 aa. It thus appears that type I is
the predominant form of a-takusan variants in the fore-
brain. The blot also shows two other minor bands, esti-
mated at 24 and 30 kD, which were also competed out
with peptide preincubation. These bands may represent
minor species of a-takusan variants that are present in
the forebrain. For example, the calculated MW of the de-
duced a7-takusan protein is 24.4 kD, and several a-taku-
san variants shown in Figure S3A could encode 30 kD
proteins. It appears that the intensity of a-takusan bands
is increased in the NR3A KO (data not shown).
We next tested whether our antibody is useful for immu-
nocytochemistry. For this purpose, HEK293 cells were
transfectedwith cDNAs encoding a fusion protein in which
EGFP was fused at the N terminus of a1-takusan (referred
to as EGFP-a1). The antibody detected EGFP-a1, as evi-
denced by colocalization of green fluorescence and im-
munosignal (Figure 3B). No anti-takusan signals were
Neuron
Takusan Gene Family Regulates Synaptic ActivityFigure 3. Characterization of Endogenous a-Takusan Proteins
(A) Immunoblot of the PSD fraction prepared from adult C57BL/6 WT mouse brain using a-takusan antibody. The antibody detected a major band
at 17 kD and minor bands at 24 and 30 kD in this preparation.
(B) Immunocytochemistry with a-takusan antibody of HEK293 cells expressing exogenous EGFP-a1. Images represent EGFP-a1 fluorescence
(green, top left), anti-a-takusan staining (red, top right), Nomarsky (bottom left), and overlay (bottom right). The staining pattern of a-takusan approx-
imates that of EGFP; additionally, a cell not expressing EGFP-a1 does not stain for a-takusan (indicated by the arrow).
(C) Selective expression of a-takusan in MAP-2-positive neurons. Mixed neuronal/glial cultures of hippocampal cells were costained for a-takusan/
MAP-2 or a-takusan/GFAP. The two images at the top represent an overlay of a-takusan (red) and eitherMAP-2 (green; left) or GFAP (green; right). The
images on the bottom represent a-takusan staining only. The a-takusan antibody detected strong signals in MAP-2-positive (neuronal) cells, but only
weak signals in GFAP-positive (astrocytic) cells. In the MAP-2-positive cells, a-takusan localized to both dendrites and cell bodies. Scale bar, 10 mm.detected in the cells expressing EGFP alone (data not
shown). We then performed immunocytochemistry on
mixed neuronal/glial cell cultures prepared from hippo-
campi isolated from E18 C57BL/6 mice. Figure 3C shows
cells costained with either a-takusan/MAP-2 or a-takusan/
GFAP. a-Takusan signals are present in neurites and cell
bodies of MAP-2-positive cells, while only weak signals
are seen in GFAP-positive cells. These experiments sug-
gest that a-takusan is primarily expressed in neurons
rather than astrocytes.
a-Takusan Dimerizes (or Oligomerizes)
in Transfected HEK293 Cells
The conserved sequence among a-takusan proteins con-
sists of a predicted coiled-coil domain, which often medi-
ates protein-protein interactions as well as dimerization or
oligomerization (Cohen and Parry, 1990). In order to test
whether a-takusan dimerizes, we performed coimmuno-
precipitation (IP) experiments on cells transfected with
two fusion proteins of a1-takusan. We chose a1 among
the a-takusan variants because we frequently observed
this clone in many experiments on mouse brain. In addi-
tion, a1-takusan belongs to the type I form of a-takusan
variants, which appears to predominate in themouse fore-
brain (Figure 3A). The two fusion proteins used in this
study were EGFP-a1 and myc-a1, the latter containing
a myc-tag fused at the N terminus of a1-takusan. We co-
transfected HEK293 cells with EGFP-a1 and myc-a1. Ly-
sates prepared from transfected cells (inputs) were di-
rectly probed with anti- EGFP and anti-myc antibodies
to verify expression of the fusion proteins (Figure 4A;
two top panels). We then performed co-IP experiments
using anti-EGFP and anti-myc antibodies in either order.Thus, we precipitated lysates with anti-myc and blotted
with anti-EGFP (Figure 4A, third panel from the top), or
precipitated with anti-EGFP and blotted with anti-myc
(Figure 4A, bottom panel). The bands in the third lane of
the bottom two panels show that EGFP-a1 had associ-
ated with a1-myc in transfected HEK293 cells. These
data are consistent with the notion that the coiled-coil do-
mains of a-takusan proteins mediate self-dimerization or
oligomerization of these proteins.
Select a-Takusan Variants Associate with PSD-95
We next examined the subcellular localization of endoge-
nous a-takusan proteins by performing immunocyto-
chemistry on cultured hippocampal neurons using our
a-takusan antibody. Figure 4B shows the pattern of
a-takusan immunostaining and its relative relationship
with PSD-95 and a1-GABAA-receptor signals. In den-
drites, a-takusan was localized in small clusters. The
a-takusan signal overlapped in part with PSD-95 but
exhibited little overlap with GABAA receptors. Taken to-
gether with the additional data shown below, this finding
is consistent with the notion that a-takusan is primarily
localized at excitatory synapses.
The partial but not exclusive overlap between a-takusan
and PSD-95 signals observed in Figure 4B may be related
to the fact that some a-takusan variants contain C-termi-
nal sequences that are predicted to bind to class I PDZ do-
mains, while other variants do not. We therefore tested the
ability of six a-takusan proteins (a1–a6) to bind PSD-95 in
coimmunoprecipitation experiments. Figure 4C shows
that a1- and a5-takusan associated with PSD-95 when
these proteins were coexpressed in COS-7 cells. In con-
trast, a2, a3, a4 and a6 did not bind PSD-95 in COS-7Neuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc. 75
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Takusan Gene Family Regulates Synaptic ActivityFigure 4. a1-Takusan Dimerizes and a-Takusan Variants with Different C Termini Manifest Differential Ability to Associate with
PSD-95
(A) Self-dimerization of a1-takusan. HEK293 cells were transfected with EGFP-a1 alone, myc-a1 alone, or the combination of both, as indicated at the
top of the panel. The top two panels are immunoblots of cell extracts (inputs) probed with anti-EGFP and anti-myc antibodies, respectively. The bot-
tom two panels show co-IP experiments in which antibodies used for IP and blotting are shown. In the right-most lane of these two panels, mock IPs
were performed (antibodies were absent during the IP procedure). The experimental scheme is shown at the bottom.
(B) Immunocytochemistry of cultured hippocampal neurons decorated by antibodies against PSD-95 (green), GABAA receptor (blue), and a-takusan
(red). a-Takusan proteins appear as clusters or aggregates in dendrites. Some a-takusan signals overlapwith PSD-95, while others do not. a-Takusan
signals generally do not overlap with GABAA receptors. Scale bar, 2 mm.
(C) Co-IP experiments from COS-7 cells expressing a-takusan variants and PSD-95. COS-7 cells were transfected with PSD-95 (lane 1), one of six
takusan variants (a1–a6) fused with EGFP at the N termini (lanes 2–7), or the combination of PSD-95 and one takusan variant (lanes 8–13). In the top
two panels, lysate inputs were probed with anti-PSD-95 or anti-a-takusan antibody to verify their expression. In the bottom panel, the lysates were
immunoprecipitated with anti-PSD-95 antibody; precipitates were then probed with anti-takusan antibody. The data show that a1- and a5-takusan
coimmunoprecipitated with PSD-95, while other variants tested did not.
(D) Immunocytochemistry of cultured hippocampal neurons expressing EGFP, EGFP-a1, or EGFP-a2, stainedwith antibodies against PSD-95 (red) or
synapsin (blue). These images show that both EGFP-a1 and EGFP-a2 appear to be localized at postsynaptic sites. In addition, forced expression of
EGFP-a1 or -a2 increases the degree of PSD-95 clustering in these neurons compared to control cells expressing EGFP alone. Scale bar, 5 mm.
(E) Quantification of PSD-95 aggregates in neurons expressing EGFP (n = 8), EGFP-a1 (n = 8), or EGFP-a2 (n = 9). The number of total PSD-95 ag-
gregates in dendrites (left) and PSD-95 aggregates juxtaposed to synapsin (right) were counted, and their density was calculated per 10 mmdendritic
length (mean density ± SEM; *p < 0.05, **p < 0.01, one-way ANOVA).
(F) Association of a2-takusan with PSD-95 in the presence of a1-takusan. Immunoblots of lysates and IPs prepared from cells cotransfected with
plasmids containing myc-a1, EGFP-a2, and PSD-95. In each immunoblot, the left lanes are loaded with lysates (inputs), the middle lanes co-IP ex-
periments, and the right lanes mock IPs. The antibodies used for IP and blotting are shown next to each panel. Top panel shows that myc-a1 asso-
ciates with EGFP-a2. The two other panels show the association of EGFP-a2 and PSD-95. Since (C) shows that a2-takusan does not directly bind to
PSD-95, this association is probably indirect via a1-takusan (shown schematically at bottom of figure).76 Neuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc.
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program. The data suggest that disparate a-takusan vari-
ants possess different functional properties.
Additionally, if the physical association between a1-
takusanandPSD-95 isphysiologically relevant, theproteins
might be expected to colocalize in neurons. To test this
idea, we constructed another fusion protein, EGFP-a2,
in which EGFP is linked to the N terminus of a2-takusan,
and tested it along with EGFP-a1. We chose these two
variants for two reasons. (1) a1 and a2 are two of the
most prevalent species that we isolated in our cloning ef-
forts. (2) The amino acid sequences of a1 and a2 are iden-
tical except for two residues (H/Y at residue 121 and I/K at
residue 150 for a1/a2, respectively). Therefore, any differ-
ence we observe between two variants can be attributed
to these two residues. We then transduced these fusion
proteins into cultured hippocampal neurons with a Semliki
Forest Virus (SFV) vector. Figure 4D shows the results of
immunocytochemical experiments on neurons expressing
EGFP-a1 or -a2. The green fluorescence patterns show
the localization of the fusion proteins in cells costained
with antibodies against PSD-95 or the presynaptic protein
synapsin. Both EGFP-a1 and -a2 form puncta within den-
drites (Figure 4D, green). These proteins thus appeared to
localize close to PSD-95. In contrast, there was little, if
any, overlap between EGFP-a1/-a2 and synapsin. Upon
closer examination (Figure 4D, overlay), there was a differ-
ence between the localization of EGFP-a1 and -a2with re-
spect to PSD-95. Namely, EGFP-a1 and PSD-95 often
overlapped, indicating their colocalization within den-
drites. In contrast, some EGFP-a2 fluorescence overlap-
ped with PSD-95, while other fluorescent signals did not.
The distinct localizations of these two a-takusan variants
may be due to the difference in their ability to associate
with PSD-95. Furthermore, the patterns of signals gener-
ated by the a-takusan antibody (Figure 4B) can be ex-
plained as a mixture of localization patterns of the two
types of a-takusan variants: those that directly bind
PSD-95 (such as a1) and those that do not (such as a2).
Interestingly, overexpressing a-takusan in cultured neu-
rons might mimic conditions of NR3A-deficient neurons to
some extent. We thus examined whether forced expres-
sion of a1- or a2- takusan could induce physiological ef-
fects in the transduced neurons. When neurons express-
ing EGFP-a1 or EGFP-a2 were stained with PSD-95
antibodies, we observed an increase in the number of
PSD-95 clusters compared to neurons expressing the
control protein EGFP. We quantified the number of PSD-
95 clusters in neurons expressing EGFP, EGFP-a1, or
EGFP-a2 and then calculated their density per 10 mmden-
dritic length. As shown in Figure 4E (left), we found a signif-
icant increase in the number of PSD-95 clusters after
forced expression of EGFP-a1 (21.62 ± 1.56; n = 8) or
EGFP-a2 (16.49 ± 1.28; n = 9) compared to that in control
neurons (8.97 ± 1.47; n = 8). EGFP-a1manifested a greater
effect than EGFP-a2. In addition, we quantified the num-
ber of PSD-95 clusters that were juxtaposed to synapsin
(Figure 4E, right). This value measures the degree ofPSD-95 clustered at presumed synaptic sites. We ob-
served a significant increase in the number of PSD-95/
synapsin clusters after forced expression of EGFP-a1
(3.97 ± 0.40) or EGFP-a2 (3.71 ± 0.39) compared to control
neurons (2.04 ± 0.25). These results suggest that forced
expression of EGFP-a1 or EGFP-a2 promotes synaptic
clustering of PSD-95.
The aforementioned results reveal only subtle differ-
ences between the subcellular localization and synaptic
effects of EGFP-a1 and EGFP-a2. The actions of a1-taku-
san may be accounted for at least in part via association
with PSD-95. However, since a1-takusan can both inter-
act directly with PSD-95 and also dimerize (or oligomerize)
with itself, we wondered whether a2-takusan might asso-
ciate with a1-takusan, thereby indirectly interacting with
PSD-95. To test this idea, HEK293 cells were transfected
with myc-a1, EGFP-a2, and PSD-95 cDNAs. Cell lysates
were prepared, and three different co-IP experiments
were performed. First, lysates were precipitated with
anti-EGFP and blotted with anti-myc (Figure 4F, top
panel). This experiment showed that myc-a1 and EGFP-
a2 bind to each other in cell lysates. Next, lysates were
either precipitated with anti-EGFP and blotted with anti-
PSD-95 (middle panel) or precipitated with anti-PSD-95
and blotted with anti-EGFP (Figure 4F, bottom panel).
These experiments show that EGFP-a2 and PSD-95 asso-
ciate with each other in cell lysates. Since we have shown
that EGFP-a2does not directly bind toPSD-95 (Figure 4C),
EGFP-a2 likely associates with PSD-95 via its interaction
with myc-a1 (Figure 4F, scheme).
Forced Expression of a1- or a2-Takusan Increases
Dendritic Spine Density and Surface Expression
of GluR1 Protein
Forced expression of PSD-95 in cultured neurons has
been shown to promote maturation of dendritic spines
and synaptic clustering of the AMPAR subunit GluR1,
but not NR1 (El-Husseini et al., 2000). We thus hypothe-
sized that the increase in the number of PSD-95 clusters
observed in neurons expressing EGFP-a1 or EGFP-a2
might lead to similar consequences. To test this hypothe-
sis, we transfected hippocampal neurons cultured for%7
days in vitro (DIV) with a lentiviral vector encoding EGFP in
order to visualize dendritic structures. Cells were then
superinfected with SFV encoding mCherry, mCherry-a1,
or mCherry-a2 at 21 DIV. mCherry-a1 and mCherry-a2
are fusion proteins between mCherry and a1-takusan or
a2-takusan, respectively. Twenty-four hours later, cells
were fixed, the number of dendritic spines counted, and
their density calculated. As shown in Figures 5A and 5B,
forced expression of mCherry-a1 or mCherry-a2 resulted
in a significant increase in the density of dendritic spines
compared to control neurons. There was no significant
difference between the effects of mCherry-a1 and
mCherry-a2.
We next examined whether forced expression of EGFP-
a1 or -a2 might enhance surface expression of GluR1.
Twenty-four hours after transduction, we prepared totalNeuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc. 77
Neuron
Takusan Gene Family Regulates Synaptic ActivityFigure 5. Forced Expression of a1- or
a2-Takusan in Cultured Hippocampal
Neurons Increases Dendritic Spine Den-
sity and Surface GluR1 Labeling
(A) Dendritic spines of cultured hippocampal
neurons expressing mCherry alone (left),
mCherry-a1 (center), or mCherry-a2 (right).
Dendritic structures were visualized by EGFP
expressed from a lentivirus. The size and num-
ber of dendritic spines increased in neurons
expressing mCherry-a1 or -a2 compared to
cells expressing mCherry alone. Scale bar,
2 mm.
(B) Quantification of dendritic spine densities in
hippocampal cells expressing control mCherry
alone (n = 7), mCherry-a1 (n = 7), or mCherry-
a2 (n = 7). The density of dendritic spines (the
number of spines per 10 mm) is significantly
higher in cells expressing mCherry-a1 or
mCherry-a2 than in control (mean ± SEM;
**p < 0.01, one-way ANOVA).
(C) Immunoblots of total and biotin-labeled
(surface) proteins in hippocampal neurons in-
fected with EGFP alone, EGFP-a1, or EGFP-
a2. Proteins were subjected to immunoblotting
using antibodies against GluR1, NR1, or the a1
subunit of GABAA.
(D) Quantification of total or surface GluR1,
NR1, or GABAA-a1 proteins. Intensities of im-
munoreactive bands were quantified relative
to the control bands in four different experi-
ments. Surface expression of GluR1, but not
NR1 or GABAA receptor subunits, significantly
increased after forced expression of EGFP-a1
or EGFP-a2 (mean ± SEM; *p < 0.05, **p <
0.01, one-way ANOVA).
(E) Immunocytochemistry of GluR1 surface la-
beling (red, bottom panel) on neurons express-
ing EGFP, EGFP-a1, or EGFP-a2. Scale bar,
5 mm.
(F) Quantification of surface GluR1 labeling on
dendrites. Mean intensity and SEM of GluR1
surface staining measured on dendritic mem-
brane (n = 40 per sample). Forced expression
of EGFP-a1 or -a2 led to an increase in
GluR1 surface labeling (**p < 0.01, one-way
ANOVA).or biotin-labeled (surface) lysates from infected cells. As
shown in Figure 5C (top), forced expression of EGFP-a1
and EGFP-a2 showed no effect on the level of expression
of GluR1, NR1, or the a1 subunit of the GABAA receptor in
total cell lysates. In contrast, forced expression of EGFP-
a1 or EGFP-a2 increased the level of expression of GluR1,
but not that of NR1 or a1-GABAA, in biotin-labeled frac-
tions of lysates (Figure 5C, bottom). We then quantified
the intensity of bands in multiple immunoblots and deter-
mined that forced expression of either EGFP-a1 or -a2
increased surface expression of GluR1 by 1.7- to
1.8-fold (Figure 5D).
We next performed immunohistochemistry for surface
GluR1 on neurons expressing EGFP, EGFP-a1, or
EGFP-a2 (Figure 5E). We quantified the intensity of
GluR1 signal on the surface of dendrites (Figure 5F) and78 Neuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc.cell bodies (data not shown). In both cases, GluR1 signal
was significantly higher in neurons expressing EGFP-a1
(51.23 ± 5.71, n = 40) or EGFP-a2 (47.10 ± 6.64, n = 40)
than in control neurons (17.38 ± 1.71, n = 40; p < 0.01).
The effect of EGFP-a1 on GluR1 surface staining was
not significantly different from that of EGFP-a2. In sum-
mary, the experiments presented in Figure 5 show that
forced expression of a1- or a2- takusan in hippocampal
neurons increased dendritic spine maturation and surface
expression of GluR1.
Forced Expression of a1- and a2-Takusan
Differentially Modifies AMPA-
and NMDA-Receptor Properties
We next tested whether increased surface expression
of GluR1 in neurons expressing EGFP-a1 or -a2 is
Neuron
Takusan Gene Family Regulates Synaptic ActivityFigure 6. Forced Expression of a1- or
a2-Takusan Differentially Modifies
AMPA- and NMDA-Receptor Activity in
Cultured Hippocampal Neurons
(A) Representative traces of NMDA- and
AMPA-induced whole-cell currents in neurons
infected with SFV encoding EGFP (green),
EGFP-a1 (blue), or EGFP-a2 (red).
(B) Normalized density of NMDA- and AMPA-
induced currents (mean ± SEM) from neurons
expressing EGFP (n = 7), EGFP-a1 (n = 9), or
EGFP-a2 (n = 9 for NMDA; n = 8 for AMPA).
The current density of neurons expressing
EGFP was arbitrarily set at 1. *p < 0.05.
(C) Desensitization index (the ratio of the
steady state to the peak current amplitudes)
of NMDA-induced currents in neurons ex-
pressing EGFP (n = 7), EGFP-a1 (n = 9), or
EGFP-a2 (n = 9). Values are mean ± SEM.
*p < 0.05.
(D) Representative traces of mEPSCs recorded
from cultured hippocampal neurons after in-
fection with SFV encoding EGFP, EGFP-a1,
or -a2 (top). To compare the shape of the cur-
rents, the same traces are presented with the
peaks normalized to the same point (bottom).
No significant difference was found in the
shape of the currents.
(E) Cumulative amplitude histograms are plot-
ted from neurons infected with EGFP (n = 12 cells; 200 events/cell), EGFP-a1 (n = 11 cells; 200 events/cell), or EGFP-a2 (n = 10 cells; 200 events/
cell). mEPSC amplitude increased in EGFP-a1 and EGFP-a2 compared to EGFP-infected neurons (p < 0.001 for each by Kolmogorov-Smirnov
test). The difference between the effects of a1- and a2-takusan was not significant. Values are mean ± SEM.accompanied by altered electrophysiological properties
of these cells. To this end, we performed whole-cell patch
recordings from these neurons. Figure 6 shows represen-
tative traces and a summary of the results of these electro-
physiological studies. As shown in Figures 6A and 6B,
AMPA-induced currents were enhanced after forced ex-
pression of EGFP-a1 (2.00 ± 0.34, n = 9) or EGFP-a2
(2.50 ± 0.46, n = 8) compared to those of control neurons
(normalized to 1 ± 0.22, n = 7; p < 0.001). As an additional
control, we recorded from nontransfected cells and
EGFP-transfected cells under the same conditions and
did not observe a significant difference (data not shown).
These effects of EGFP-a1 and EGFP-a2 on AMPA-
induced currents are consistent with the observation
that forced expression of these molecules increased sur-
face expression of GluR1 (Figure 5).
In contrast, steady-state NMDA current amplitude (Fig-
ures 6A and 6B) was not significantly different among neu-
rons expressing EGFP (normalized to 1 ± 0.19, n = 7),
EGFP-a1 (1.06 ± 0.22, n = 9), or EGFP-a2 (1.31 ± 0.31,
n = 9). However, forced expression of EGFP-a1, but not
EGFP-a2, resulted in a change in the desensitization kinet-
ics of NMDA-induced currents (Figures 6A and 6C). Spe-
cifically, NMDA-induced currents in neurons expressing
EGFP-a1 (index 0.84 ± 0.19, n = 9) exhibited less apparent
desensitization than control neurons (index 0.61 ± 0.23,
n = 7) and neurons expressing EGFP-a2 (index 0.66 ±
0.22, n = 9). Based on forced expression studies, a-taku-
san variants appear to modulate excitatory neurotrans-mission by two distinct mechanisms. Namely, they may
enhance trafficking of AMPAR subunits to the surface
via a direct or indirect interaction with PDZ-containing
proteins, whereas they may modify NMDAR properties
through a direct interaction with PDZ-containing proteins
(i.e., mediated by a1- but not a2-takusans).
Finally, forced expression of EGFP-a1 or EGFP-a2 in
cultured hippocampal neurons increased the amplitude
of AMPAR-mediated miniature excitatory postsynaptic
currents (mEPSCs) (Figures 6D and 6E). Although the am-
plitude of these currents was enhanced by forced expres-
sion of EGFP-a1 or EGFP-a2 (Figure 6D, top), the shape of
currents was not significantly altered (Figure 6D, bottom).
The difference between the effects of a1 and a2 on the
amplitude was not significant (Figure 6E). These results
suggest that both a1- and a2-takusan increase the num-
ber of AMPAR subunits at functional synapses.
Transfection of Hippocampal Neurons with siRNAs
that Target a-Takusan Variants Reduces Surface
Expression of GluR1
We next tried to interfere with the activity of endogenous
a-takusan molecules using RNAi methods. We designed
siRNAs that would knock down asmany a-takusan variant
mRNAs as possible in the following manner. We analyzed
the coding sequence of a1-takusan using siRNA design-
ing programs and identified two 21 nt long sequences,
NN001 and NN002 (see Supplemental Experimental
Procedures for their sequences), each of which wasNeuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc. 79
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Takusan Gene Family Regulates Synaptic ActivityFigure 7. a-Takusan siRNA Knocks Down Exogenous Expression of a1-Takusan in HEK293T Cells and Reduces Surface Expres-
sion of GluR1 in Cultured Neurons
(A and B) HEK293 cells were transfected with EGFP-a1 alone or EGFP-a1 together with control siRNA (siCONTROL), siRNA NN001, or siRNA NN002.
Twenty-four hours after transfection, cells were examined under fluorescence microscopy (A) or subjected to immunoblotting (B) using anti-takusan
or anti-tubulin antibodies. The results show that the level of exogenously expressed a1-takusan was significantly reduced by both siRNAs but not
control. NN002 was more effective than NN001 in the ability to knock down a1-takusan expression.
(C–E) Effects of NN002 transfection into cultured hippocampal neurons at 12 DIV. The EGFP plasmid (pEGFP-N2) was cotransfected in these cells
to visualize cell bodies and dendrites. (C) Twenty-four hours after siRNA transfection, immunocytochemistry using anti-a-takusan was performed
and signal intensity quantified (mean ± SEM). Transfection of NN002 reduced a-takusan signals by 50% compared to transfection of siCONTROL.
*p < 0.05. (D) Surface staining of GluR1 on dendrites treated with siCONTROL or NN002. Scale bar, 5 mm. (E) Quantification of the intensity of surface
GluR1 signal localized over dendrites filled with EGFP. Transfection of NN002 into cultured neurons reduced the surface expression of GluR1
by 50% in the dendrites of these cells compared to control siRNA transfection. Values are mean ± SEM. **p < 0.01.completely conserved among all of the a-takusan variant
cDNAs that we isolated. As expected, the mouse genome
carries multiple sites that are homologous to these se-
quences. Specifically, we found 35 and 54 sites that
showed 100% homology with the NN001 and NN002
sequences, respectively. We examined the sequences
surrounding all of these sites and determined that they
all encoded a-takusan variants. Furthermore, 16 out of
18 a-takusan variant cDNAs that are presented in Fig-
ure S3B manifest a perfect match with NN002, while the
other two have a single-base mismatch. These observa-
tions indicate that NN001 and NN002 siRNAs, particularly
the latter, can potentially knock downmost, if not all, of the
endogenous a-takusan variants.
We cotransfected HEK293 cells with NN001, NN002, or
a negative control siRNA (siCONTROL nontargeting pool,
Dharmacon), together with an expression vector carrying
EGFP-a1. Figures 7A and 7B show fluorescence micros-
copy and Western blotting using anti-takusan antibody
performed 24 hr after the transfection. While NN001 re-80 Neuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc.duced the level of newly synthesized EGFP-a1 by 50%
compared to control, NN002 eliminated EGFP-a1 expres-
sion altogether (within the limits of protein detection).
We next examined the effects of NN002 on cultured hip-
pocampal neurons. We transfected neurons with siRNAs
together with an EGFP expression vector (pEGFP-N2,
Clontech). We used the latter vector in order to visualize
transfected neurons and their dendrites. Initially, we as-
sessed the effects of NN002 on the expression levels of
a-takusan proteins. As shown in Figure 7C, transfection
of NN002 in cultured hippocampal neurons reduced the
intensity of a-takusan immune signals by 50% com-
pared to that in neurons treated with siCONTROL, indicat-
ing that NN002 effectively knocked down endogenous ta-
kusan. The level of knock down by NN002 in cultured
neurons was not as efficient as observed in HEK293 cells.
This is likely due to the fact that there are pre-existing
a-takusan proteins in cultured neurons prior to siRNA
treatment, while HEK293 cells do not express endoge-
nous a-takusan proteins. Alternatively, a-takusan variants
Neuron
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the NN002 siRNA.
Having established that NN002 significantly reduces the
level of a-takusan proteins in cultured hippocampal neu-
rons, we next performed surface staining for GluR1 on
these neurons (Figure 7D) and quantified the intensity of
GluR1 signal localized over dendritic processes filled
with EGFP (Figure 7E). The results show that transfection
of cultured neurons with NN002 reduced the surface ex-
pression of GluR1 by 50% in the dendrites. Since the
NN002 sequence bore no sequence homology with
GluR1 mRNAs, the reduction in GluR1 surface expression
in these cells was likely caused by the knock down of
a-takusan proteins. The loss of function observed in these
experiments suggests that endogenous a-takusan pro-
teins facilitate surface expression of AMPAR subunits
such as GluR1.
Transfection of Hippocampal Neurons with shRNAs
that Target a-Takusan Variants Reduces GluR1
Surface Expression, PSD-95 Synaptic Clusters,
and Dendritic Filopodia-like Protrusions
We next utilized shRNA technology via infection with len-
tiviral vectors because this method has the advantage of
achieving significantly higher transduction efficiencies in
cultured neurons compared to transfectionmethods avail-
able for siRNA. The shRNA sequence derived from the
NN002 siRNA sequence was inserted downstream from
the pH1 promoter in a lentiviral vector that also contained
a cDNA encoding EGFP driven by the human phospho-
glycerate kinase promoter (hPGK). This approach allowed
us to identify infected cells by their EGFP expression.
We infected cultured hippocampal neurons with lentivi-
ral vectors encoding scrambled nontargeting control
shRNA or a-takusan shRNA and stained them with anti-
a-takusan antibody (Figure 8A). Quantification of the sig-
nals showed that a-takusan expression was significantly
reduced in neurons expressing a-takusan shRNA (0.49 ±
0.08; n = 10; value normalized to control) compared to
neurons expressing control shRNA (1 ± 0.05; n = 10;
Figure 8D). This result shows that the shRNA effectively
knocked down a-takusan proteins in these neurons. We
next examined the effect of the a-takusan shRNA on the
expression of GABAA receptors by immunocytochemistry.
Figure 8B (top panel) presents a1-GABAA-receptor immu-
nostaining of hippocampal neurons expressing control
shRNA or a-takusan shRNA. Quantification of the signals
revealed no significant difference between cells express-
ing a-takusan shRNA (1.25 ± 0.18; n = 10) and cells ex-
pressing control shRNA (1 ± 0.10; n = 10). This result is
consistent with the observation that a-takusan does not
colocalize with GABAA receptors in neurons (Figure 4B).
It is also consistent with the finding that forced expression
of a-takusan did not alter GABAA-receptor expression
(Figures 5C and 5D).
We next examined the effects of a-takusan shRNA on
events that we had observed were altered with forced ex-
pression of a-takusan cDNAs in hippocampal neurons.Specifically, using immunocytochemistry we examined
surface expression of GluR1 and synaptic clustering of
PSD-95 in neurons expressing shRNA (Figure 8B). When
quantified (Figure 8D), the intensity of surfaceGluR1 signal
in neurons expressing a-takusan shRNA (0.39 ± 0.06;
n = 12) was significantly lower than that in control neurons
(1.0 ± 0.19; n = 12). Surprisingly, the intensity of total
GluR1 signal in neurons expressing a-takusan shRNA
(0.37 ± 0.03; n = 8) was reduced compared to control neu-
rons (1.0 ± 0.11; n = 8). We then quantified PSD-95 clus-
tering by measuring the density of PSD-95 aggregates
or the density of PSD-95 aggregates juxtaposed to synap-
sin signals. The density of PSD-95 aggregates in neurons
expressing a-takusan shRNA (0.41 ± 0.06; n = 10) was sig-
nificantly lower than that in control neurons (1.0 ± 0.09; n =
10). Similarly, the density of PSD-95 aggregates juxta-
posed to synapsin in neurons with a-takusan shRNA
(0.32 ± 0.05; n = 10) was lower than that in control cells
(1.0 ± 0.10; n = 10).
Finally, these neurons were examined for dendritic mor-
phology (Figure 8C). For technical reasons, the neurons
we used in shRNA experiments were young and did not
yet possess mature dendritic spines. Nonetheless, the ef-
fect of a-takusan shRNA expression was evident when we
quantified the number of dendritic filopodia-like protru-
sions (Figure 8D), which are known to be harbingers for
spine formation (Papa and Segal, 1996). The density of
these protrusions was significantly reduced in neurons ex-
pressing a-takusan shRNA (0.47 ± 0.10; n = 6) compared
to control cells (1.0 ± 0.10; n = 8). The ramifications of
these observations are discussed below.
DISCUSSION
We have identified a large gene family, designated a-taku-
san, whose expression is upregulated in the brains of
NR3A KOmice compared to WT mice. Since the absence
of NR3A has been shown to increase NMDAR activity (Das
et al., 1998; Sasaki et al., 2002), our findings are consistent
with the notion that upregulation of a-takusan gene ex-
pression is likely caused by NMDAR hyperactivation in
mice lacking NR3A. It is also possible, however, that taku-
san upregulation in NR3A KO mice might be caused by
downregulation of the putative excitatory glycine-receptor
activity composed of NR1 and NR3A subunits (Chatterton
et al., 2002). Either way, the observation that upregulation
of a-takusan occurs in areas of the brain where NR3A is
normally expressed suggests that these effects are likely
cell-autonomous.
In our microarray experiments, Q-PCR determinations,
and Northern blot analyses, the probes we used do not
distinguish among the various a-takusan variants. There-
fore, if only a small fraction of the takusan genes are reg-
ulated by an NR3A-dependent mechanism, our results
may underestimate the true impact of NR3A deletion.
Intriguingly, we have found that multiple a-takusan var-
iants are expressed in the mouse brain. From WT adultNeuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc. 81
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Takusan Gene Family Regulates Synaptic ActivityFigure 8. a-Takusan shRNA Knocks Down Endogenous a1-Takusan and Alters Dendritic Phenotype in Cultured Neurons
(A) Reduction of a-takusan protein in neurons infected with a lentiviral vector expressing a-takusan shRNA. Cultured hippocampal neurons were
infected with lentiviral vectors encoding scrambled nontargeting-control or a-takusan shRNA. The vectors carried EGFP cDNA whose expression
allowed identification of infected cells.
(B) Effects of a-takusan shRNA on GABAA receptor, surface GluR1, total GluR1, and PSD-95/synapsin signals. Cultured hippocampal neurons were
infected with lentiviral vectors encoding control or a-takusan shRNA. Cells were subsequently subjected to immunohistochemistry using various
antibodies as indicated. The images obtained here were used for the quantitative analyses presented in (D), below.
(C) Effect of a-takusan shRNA on dendritic morphology. Neurons infected with lentiviral vectors encoding control or a-takusan shRNA were identified
by expression of EGFP and their images captured by confocal microscopy. The gross cell morphology was not affected by a-takusan shRNA (top
panel). The number of dendritic filopodia-like protrusions, however, appeared to be reduced by a-takusan shRNA (bottom panel).
(D) Quantification of immunosignals, PSD-95 clustering, and dendritic morphology in neurons infected with lentivirus expressing control or a-takusan
shRNA. For the first four columns, the density of immunosignal for a-takusan, GABAA, surface GluR1 (S. GluR1), or total GluR1 (T. GluR1) was quan-
tified in cells expressing control or a-takusan shRNA. For the next two columns, the density of PSD-95 clustering and PSD-95 clustering juxtaposed to
synapsin was quantified. For the last column, the density of dendritic filopodia-like protrusions was quantified. For each measurement, the values
obtained for cells expressing a-takusan shRNA were normalized to the mean value obtained for cells expressing control shRNA. Error bars are
mean ± SEM. Expression of a-takusan shRNA did not alter GABAA-receptor signal in these neurons, but reduced signal intensities for a-takusan,
surface GluR1, and total GluR1. Similarly, a-takusan shRNA reduced the density of PSD-95 aggregates, PSD-95 aggregates juxtaposed to synapsin,
and dendritic protrusions in these neurons. **p < 0.01; scale bars, 10 mm.brain and E18-cultured neurons, we have isolated cDNAs
encoding 46 different a-takusan variants. It should be
noted that our cloning strategy targeted narrow branches
of the a-takusan family due to inherent biases imposed by
the PCR primers used in our studies. Furthermore, we lim-82 Neuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc.ited our RNA sources to tissues extracted from forebrain
and from cultured hippocampal or cortical neurons. Other
areas of the brain that express a-takusan mRNA, such as
the cerebellum, might express unique and additional sets
of a-takusan variants.
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Takusan Gene Family Regulates Synaptic ActivityDespite our best efforts to minimize the occurrence of
mutations during the PCR, we cannot completely exclude
the possibility that at least some variations were intro-
duced. However, several lines of evidence suggest that
most of the variations observed in a-takusan sequences
are authentic. (1) Variations occur only at certain positions
in the sequence. (2) Variations are reproducible from one
PCR reaction to another. (3) Each variation found in the
PCR products is present in genome sequences deposited
in GenBank.
We have made some intriguing, perhaps even peculiar,
observations regarding the diversity of the a-takusan PCR
products that we isolated. Cortical cell #4 (Table 1), for ex-
ample, expressed three variants (a34–a36) that are ex-
tremely similar to one other, presumably indicating similar
protein properties. Again, these variations are likely to be
authentic because they occur at positions where the
same variations are present in the genome. However,
the physiological role in the nervous system of such subtle
diversity remains to be seen.
The analysis presented in Figure S3B shows that the
a-takusan family is merely one branch of a much larger
takusan gene family. Some non-a-takusan cDNAs were
isolated from the whole body, testis, ovary, uterus, mam-
mary tumors, and spinal cord of mice and rats. Eight of
these genes have been reported to bemembers of a family
of testis-specific genes (Spiess et al., 2003).
Single-cell PCR experiments from hippocampal and
cortical cultures show that an individual neuron expresses
more than one a-takusan variant, and different cells
express disparate variants (Table 1). Furthermore, there
might be a cell-type-specific preference in the repertoire
of these variants. A note or caution, however, is appro-
priate in that the repertoire of a-takusan expression that
we observe in cultured neurons may not reflect the situa-
tion in vivo. This would be particularly true if electrical
activity modifies the repertoire of expression. Further
studies are needed to determine the expression of
a-takusan variants in vivo and if such expression is cell-
type dependent.
In the present study, we chose two variants—a1, which
directly binds PSD-95, and a2, which does not—for fur-
ther gain-of-function studies. When these proteins were
force expressed in cultured neurons as fusion proteins
with EGFP, both a1 and a2 led to an increase in the num-
ber of synaptic PSD-95 clusters, density of dendritic
spines, surface expression of GluR1, AMPA-induced
whole-cell currents, and AMPAR-mediated mEPSCs. It
has been established that the abundance of AMPA recep-
tors correlates with the size of the synapse and dimen-
sions of the dendritic spine head (Matsuzaki et al., 2001;
Nusser, 2000; Takumi et al., 1999) and overexpression
of GluR2 in hippocampal neurons increases spine size
and density (Passafaro et al., 2003). Together with the ob-
servation that forced expression of PSD-95 also leads to
increased dendritic spine density, synaptic expression of
GluR1, and AMPAR-mediated EPSCs (El-Husseini et al.,
2000), the effects of takusan proteins on PSD-95 cluster-ing, dendritic spine density, andGluR1 surface expression
are likely related.
An important question concerns the mechanism
whereby a1- and a2-takusan induce synaptic events in
transfected neurons. We found evidence that a1-takusan
directly associates with PSD-95 to reorganize postsynap-
tic density complexes. Although EGFP-a2-takusan did not
directly bind to PSD-95 in our experiments, we found that
EGFP-a2 (but not EGFP alone) could form a complex with
PSD-95 in the presence of a1. Thus, it is probable that
forced expression of a2 leads to dimerization with endog-
enous a-takusan variants (such as a1 or a5), which in turn
bind to PSD-95; these a-takusan dimers or oligomers may
well be responsible for the observed increase in PSD-95
clustering and other downstream effects.
We also found that EGFP-a1, but not EGFP-a2, mod-
ifies desensitization of NMDA-induced currents. Thus,
the effect on NMDA-evoked currents is likely mediated
by direct interaction between EGFP-a1 and PDZ-contain-
ing proteins, since a2 does not manifest this protein-
protein interaction. Along these lines, overexpression of
PSD-95 has been shown to reduce desensitization of
NMDA-induced currents in immature neurons indepen-
dent of NMDAR subunit composition (Li et al., 2003).
Alternatively, EGFP-a1, together with PSD-95 or another
PDZ-containing protein, might modify the composition of
NR2-containing receptors that could alter desensitization
of NMDA-induced currents.
Additionally, we have previously reported that cortical
neurons of layer V in NR3A KO mice manifest increased
dendritic spine density (Das et al., 1998). In the present
study, we show that a-takusan mRNAs are upregulated
in the same location in NR3A KO mice and that forced
expression of a-takusan increases synaptic clustering of
PSD-95 and large-headed spine density. Thus, a-takusan
may be involved in themanifestation of this dendritic spine
phenotype in NR3A KOmice. Perhaps somewhat surpris-
ingly, we had not observed increased AMPA currents in
cortical neurons isolated from NR3A KO mice relative to
WT neurons (Das et al., 1998). It is possible, however,
that loss of NR3A leads to additional events other than
the upregulation of a-takusan in these neurons, and thus
molecular contexts of NR3A-deficient cortical neurons
might differ from those of cultured hippocampal neurons
transfected with a-takusan.
Finally, we performed loss-of-function experiments
using siRNAs and shRNAs that can target the majority of
a-takusan variants. These experiments showed that
knock down of endogenous a-takusan in hippocampal
neurons generally manifested the opposite effects of over-
expression or gain of function. Namely, expression of
a-takusan shRNAs in hippocampal cultured neurons led
to reduction in surface expression of GluR1, synaptic clus-
tering of PSD-95, and density of dendritic filopodia-like
protrusions. Surprisingly, total GluR1 staining is also re-
duced by a-takusan shRNA expression. Therefore, the
loss of GluR1 surface staining in these experiments might
reflect downregulation of protein levels.Neuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc. 83
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Takusan Gene Family Regulates Synaptic ActivityWe have thus far identified extreme amplifications of ta-
kusan genes only in mice and rats. Our preliminary study
indicates that the rat genome contains >400 loci encoding
takusan variants. A detailed analysis of rat takusan genes
is a subject of future study. Possibly related to our discov-
ery of the takusan family, it was recently reported that the
human genome contains a previously unknown gene fam-
ily that is expressed in the brain (Popesco et al., 2006).
Members of that gene family encode proteins displaying
multiple copies of DUF1220, which incidentally has no
structural homology to DUF622 of the takusans. Analo-
gous to the takusan gene family in rodents, however,
the DUF1220-encoding gene family is human-lineage
specific. Although it is not clear whether takusan and
DUF1220 proteins share functional similarities, the mech-
anisms by which both gene families tremendously ampli-
fied their sizes during evolution are likely to be similar.
In summary, a-takusan proteins are likely to be involved
in the organization of postsynaptic molecules. Since dis-
parate a-takusan variants are expressed in different types
of neurons, it is possible that the binding partners and or-
ganizational attributes of the a-takusans may vary from
cell to cell. Moreover, the structural diversity of a-takusan
variants expressed in these neurons might contribute to
the functional diversity of these cells. In the future, gener-
ating mutant mice in which the various a-takusan variants
are knocked down will help identify additional cellular
functions of this newly recognized gene family.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for details of cDNA
microarray, in situ hybridization, northern blots, isolation of a-takusan
cDNAs, single-cell RT-PCR, immunoprecipitation, immunocyto-
chemistry, electrophysiological recordings, and siRNA and shRNA
treatments.
Cell Culture
Low-density primary hippocampal and cerebrocortical cultures were
prepared from newborn or E16–E18mice andmaintained in amodified
neural basal medium. See Supplemental Experimental Procedures for
more details.
Electrophysiological Recordings
Conventional whole-cell recordings were performed to record GABA-,
AMPA-, or NMDA-induced currents and AMPA mEPSCs on cultured
hippocampal neurons. See Supplemental Experimental Procedures
for details.
siRNA and shRNA Treatment
Takusan siRNAs NN001 and NN002 were designed using siRNA
Target Finder (Ambion). For siRNA experiments, we used chemically
synthesized dsRNAs. For shRNA experiments, NN002 or its scrambled
nontargeting shRNA was expressed from a lentiviral vector. See
Supplemental Experimental Procedures for details.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/55/1/69/DC1/.84 Neuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc.ACKNOWLEDGMENTS
We would like to thank Dr. Alexey Terskikh for providing us with lenti-
viral vectors, and Dr. Ruchi Bajpai for technical advice. This work was
supported in part by NIH grants P01 HD29587, R01 EY05477 (to
S.A.L.) and K12AG00975 (toG.G.T.). B.A.S. was supported by a fellow-
ship from the PhRMA foundation. S.A.L. was a Senior Scholar in Aging
Research of the Ellison Medical Research Foundation.
Received: August 25, 2006
Revised: April 11, 2007
Accepted: June 12, 2007
Published: July 5, 2007
REFERENCES
Barry, M.F., and Ziff, E.B. (2002). Receptor trafficking and the plasticity
of excitatory synapses. Curr. Opin. Neurobiol. 12, 279–286.
Carninci, P., and Hayashizaki, Y. (1999). High-efficiency full-length
cDNA cloning. Methods Enzymol. 303, 19–44.
Chatterton, J.E., Awobuluyi, M., Premkumar, L.S., Takahashi, H.,
Talantova, M., Shin, Y., Cui, J., Tu, S., Sevarino, K.A., Nakanishi, N.,
et al. (2002). Excitatory glycine receptors containing the NR3 family
of NMDA receptor subunits. Nature 415, 793–798.
Ciabarra, A.M., Sullivan, J.M., Gahn, L.G., Pecht, G., Heinemann, S.,
and Sevarino, K.A. (1995). Cloning and characterization of chi-1: a de-
velopmentally regulated member of a novel class of the ionotropic glu-
tamate receptor family. J. Neurosci. 15, 6498–6508.
Cohen, C., and Parry, D.A. (1990). a-Helical coiled coils and bundles:
how to design an a-helical protein. Proteins 7, 1–15.
Cull-Candy, S., Brickley, S., and Farrant, M. (2001). NMDA receptor
subunits: diversity, development and disease. Curr. Opin. Neurobiol.
11, 327–335.
Das, S., Sasaki, Y.F., Rothe, T., Premkumar, L.S., Takasu,M., Crandall,
J.E., Dikkes, P., Conner, D.A., Rayudu, P.V., Cheung, W., et al.
(1998). Increased NMDA current and spine density in mice lacking
the NMDA receptor subunit NR3A. Nature 393, 377–381.
Dingledine, R., Borges, K., Bowie, D., and Traynelis, S.F. (1999). The
glutamate receptor ion channels. Pharmacol. Rev. 51, 7–61.
El-Husseini, A.E., Schnell, E., Chetkovich, D.M., Nicoll, R.A., and
Bredt, D.S. (2000). PSD-95 involvement in maturation of excitatory
synapses. Science 290, 1364–1368.
El-Husseini, A.D., Schnell, E., Dakoji, S., Sweeney, N., Zhou, Q.,
Prange, O., Gauthier-Campbell, C., Aguilera-Moreno, A., Nicoll, R.A.,
and Bredt, D.S. (2002). Synaptic strength regulated by palmitate cy-
cling on PSD-95. Cell 108, 849–863.
Hollmann, M., and Heinemann, S. (1994). Cloned glutamate receptors.
Annu. Rev. Neurosci. 17, 31–108.
Husi, H., Ward, M.A., Choudhary, J.S., Blackstock, W.P., and Grant,
S.G. (2000). Proteomic analysis of NMDA receptor-adhesion protein
signaling complexes. Nat. Neurosci. 3, 661–669.
Kawai, J., Shinagawa, A., Shibata, K., Yoshino, M., Itoh, M., Ishii, Y.,
Arakawa, T., Hara, A., Fukunishi, Y., Konno, H., et al. (2001). Functional
annotation of a full-length mouse cDNA collection. Nature 409, 685–
690.
Kim, E., and Sheng, M. (2004). PDZ domain proteins of synapses. Nat.
Rev. Neurosci. 5, 771–781.
Kim, E., Niethammer, M., Rothschild, A., Jan, Y.N., and Sheng, M.
(1995). Clustering of Shaker-type K+ channels by interaction with
a family of membrane-associated guanylate kinases. Nature 378,
85–88.
Kornau, H.C., Schenker, L.T., Kennedy, M.B., and Seeburg, P.H.
(1995). Domain interaction between NMDA receptor subunits and
the postsynaptic density protein PSD-95. Science 269, 1737–1740.
Neuron
Takusan Gene Family Regulates Synaptic ActivityLi, B., Otsu, Y., Murphy, T.H., and Raymond, L.A. (2003). Developmen-
tal decrease in NMDA receptor desensitization associated with shift to
synapse and interaction with postsynaptic density-95. J. Neurosci. 23,
11244–11254.
Lipton, S.A., and Rosenberg, P.A. (1994). Excitatory amino acids as
a final common pathway for neurologic disorders. N. Engl. J. Med.
330, 613–622.
Malenka, R.C., and Nicoll, R.A. (1999). Long-term potentiation—a de-
cade of progress? Science 285, 1870–1874.
Malinow, R., and Malenka, R.C. (2002). AMPA receptor trafficking and
synaptic plasticity. Annu. Rev. Neurosci. 25, 103–126.
Matsuzaki, M., Ellis-Davies, G.C., Nemoto, T., Miyashita, Y., Iino, M.,
and Kasai, H. (2001). Dendritic spine geometry is critical for AMPA re-
ceptor expression in hippocampal CA1 pyramidal neurons. Nat. Neu-
rosci. 4, 1086–1092.
Mori, H., Manabe, T., Watanabe, M., Satoh, Y., Suzuki, N., Toki, S.,
Nakamura, K., Yagi, T., Kushiya, E., Takahashi, T., et al. (1998). Role
of the carboxy-terminal region of the GluR epsilon2 subunit in synaptic
localization of the NMDA receptor channel. Neuron 21, 571–580.
Nicoll, R.A., Tomita, S., andBredt, D.S. (2006). Auxiliary subunits assist
AMPA-type glutamate receptors. Science 311, 1253–1256.
Niethammer, M., Kim, E., and Sheng, M. (1996). Interaction between
the C terminus of NMDA receptor subunits and multiple members of
the PSD-95 family of membrane-associated guanylate kinases.
J. Neurosci. 16, 2157–2163.
Nourry, C., Grant, S.G., and Borg, J.P. (2003). PDZ domain proteins:
plug and play! Sci. STKE 2003, RE7. 10.1126/stke.2003.179.re7.
Nusser, Z. (2000). AMPA and NMDA receptors: similarities and differ-
ences in their synaptic distribution. Curr. Opin. Neurobiol. 10, 337–341.
Obenauer, J.C., Cantley, L.C., and Yaffe, M.B. (2003). Scansite 2.0:
Proteome-wide prediction of cell signaling interactions using short se-
quence motifs. Nucleic Acids Res. 31, 3635–3641.
Papa, M., and Segal, M. (1996). Morphological plasticity in dendritic
spines of cultured hippocampal neurons. Neuroscience 71, 1005–
1011.
Passafaro, M., Nakagawa, T., Sala, C., and Sheng,M. (2003). Induction
of dendritic spines by an extracellular domain of AMPA receptor sub-
unit GluR2. Nature 424, 677–681.
Perez-Otano, I., Schulteis, C.T., Contractor, A., Lipton, S.A., Trimmer,
J.S., Sucher, N.J., and Heinemann, S.F. (2001). Assembly with the NR1
subunit is required for surface expression of NR3A-containing NMDA
receptors. J. Neurosci. 21, 1228–1237.
Perez-Otano, I., Lujan, R., Tavalin, S.J., Plomann, M., Modregger, J.,
Liu, X.B., Jones, E.G., Heinemann, S.F., Lo, D.C., and Ehlers, M.D.
(2006). Endocytosis and synaptic removal of NR3A-containing
NMDA receptors by PACSIN1/syndapin1. Nat. Neurosci. 9, 611–621.
Popesco, M.C., Maclaren, E.J., Hopkins, J., Dumas, L., Cox, M.,
Meltesen, L., McGavran, L., Wyckoff, G.J., and Sikela, J.M. (2006).
Human lineage-specific amplification, selection, and neuronal expres-
sion of DUF1220 domains. Science 313, 1304–1307.Sasaki, Y.F., Rothe, T., Premkumar, L.S., Das, S., Cui, J., Talantova,
M.V., Wong, H.K., Gong, X., Chan, S.F., Zhang, D., et al. (2002).
Characterization and comparison of the NR3A subunit of the NMDA
receptor in recombinant systems and primary cortical neurons. J. Neu-
rophysiol. 87, 2052–2063.
Schnell, E., Sizemore, M., Karimzadegan, S., Chen, L., Bredt, D.S., and
Nicoll, R.A. (2002). Direct interactions between PSD-95 and stargazin
control synaptic AMPA receptor number. Proc. Natl. Acad. Sci. USA
99, 13902–13907.
Sheng, M. (2001). Molecular organization of the postsynaptic special-
ization. Proc. Natl. Acad. Sci. USA 98, 7058–7061.
Sheng, M., and Sala, C. (2001). PDZ domains and the organization of
supramolecular complexes. Annu. Rev. Neurosci. 24, 1–29.
Song, I., and Huganir, R.L. (2002). Regulation of AMPA receptors dur-
ing synaptic plasticity. Trends Neurosci. 25, 578–588.
Songyang, Z., Fanning, A.S., Fu, C., Xu, J., Marfatia, S.M., Chishti,
A.H., Crompton, A., Chan, A.C., Anderson, J.M., and Cantley, L.C.
(1997). Recognition of unique carboxyl-terminal motifs by distinct
PDZ domains. Science 275, 73–77.
Spiess, A.N., Walther, N., Muller, N., Balvers, M., Hansis, C., and Ivell,
R. (2003). SPEER—a new family of testis-specific genes from the
mouse. Biol. Reprod. 68, 2044–2054.
Steigerwald, F., Schulz, T.W., Schenker, L.T., Kennedy, M.B.,
Seeburg, P.H., and Kohr, G. (2000). C-Terminal truncation of NR2A
subunits impairs synaptic but not extrasynaptic localization of NMDA
receptors. J. Neurosci. 20, 4573–4581.
Stoll, M., Corneliussen, B., Costello, C.M., Waetzig, G.H., Mellgard, B.,
Koch, W.A., Rosenstiel, P., Albrecht, M., Croucher, P.J., Seegert, D.,
et al. (2004). Genetic variation in DLG5 is associated with inflammatory
bowel disease. Nat. Genet. 36, 476–480.
Sucher, N.J., and Deitcher, D.L. (1995). PCR and patch-clamp analysis
of single neurons. Neuron 14, 1095–1100.
Sucher, N.J., Akbarian, S., Chi, C.L., Leclerc, C.L., Awobuluyi, M.,
Deitcher, D.L., Wu, M.K., Yuan, J.P., Jones, E.G., and Lipton, S.A.
(1995). Developmental and regional expression pattern of a novel
NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J. Neuro-
sci. 15, 6509–6520.
Takumi, Y., Ramirez-Leon, V., Laake, P., Rinvik, E., and Ottersen, O.P.
(1999). Differentmodes of expression of AMPA andNMDA receptors in
hippocampal synapses. Nat. Neurosci. 2, 618–624.
Wong, H.K., Liu, X.B., Matos, M.F., Chan, S.F., Perez-Otano, I.,
Boysen, M., Cui, J., Nakanishi, N., Trimmer, J.S., Jones, E.G., et al.
(2002). Temporal and regional expression of NMDA receptor subunit
NR3A in the mammalian brain. J. Comp. Neurol. 450, 303–317.
Accession Numbers
The accession numbers for the 46 a-takusan genes (a1–a46)
described in this paper are EF651798 to EF651843.Neuron 55, 69–85, July 5, 2007 ª2007 Elsevier Inc. 85
